OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
RVVTF
Revive Therapeutics Ltd.
Ordinary Shares
N/A
N/A
N/A
N/A
Real-Time Level 2 Quote
Trade Data
News
Filings and Disclosure
Company Description
Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various programs.
Videos
Loading...
Symbol
OTCM
Last
51.00
Change
-0.15 (-0.29%)
Bid
50.25
Ask
51.40
Volume
8063
Time
15:57
